MedTrace Logo

Health-related Quality of Life in Rare Kidney Stone

NCT02124395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 365

Last updated 2022-09-02

No results posted yet for this study

Summary

Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium

Conditions

  • Primary Hyperoxaluria
  • Cystinuria
  • Adenine Phosphoribosyl Transferase Deficiency
  • Dent Disease

Interventions

OTHER

Health-related Quality of Life in Rare Kidney Stone Questionnaire

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • David Goldfarb, MD · NYU Langone Health

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • United States
  • Iceland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02124395 on ClinicalTrials.gov